Also published in GlobeNewswire:
Diverse Slate of Corporate Directors Become NACD Fellows - GlobeNewswire
x hide permanently

Cara Therapeutics Expands Board of Directors with Appointment of Susan Shiff, Ph.D., M.B.A.


Cara Therapeutics, Inc. (Nasdaq: CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities designed to alleviate pruritus by selectively targeting peripheral kappa opioid receptors, or KORs, today announced the appointment of Susan Shiff, Ph.D., M.B.A., to its Board of Directors...

Mentions: Nasdaq Board of Directors Cara Therapeutics, Inc.